The MHA hosted a webinar Jan. 9 about a proposed policy from the Michigan Department of Health and Human Services (MDHHS) that could have a significant impact on current and future use of the 340B prescription drug program for hospitals in Michigan. A recording and materials are available on the MHA Community site.
The Medicaid Health Plan Pharmacy Drug Coverage Transition (1936-Pharmacy) proposal would carve all outpatient prescription drugs out of Medicaid managed care coverage, instead billing these drugs at the point-of-sale to the state of Michigan’s pharmacy benefit manager under fee-for-service payment.
During the webinar, William von Oehsen and Peggy Tighe of the Powers Law Firm in Washington, DC, covered the impact of the proposed policy on 340B hospitals currently using 340B pricing for outpatient prescription drugs, as well as the future financial limits this policy would impose on hospitals that may wish to begin using 340B pricing in the future.
Comments on the proposed policy 1936-Pharmacy are due Jan. 17. This is a second open comment period; the MHA’s comments from the first comment period are available to assist members. Members who are affected now or could be affected in the future are asked to comment on this proposed policy and share their comments with the MHA. Comments should be submitted to the MDHHS.